Enzyme Replacement and Immunosuppression in Heart Transplant Recipients with Fabry Cardiomyopathy: A 7-Year Case Study. [PDF]
Muras-Szwedziak K+3 more
europepmc +1 more source
Early Steroid Withdrawal in Kidney Transplant Recipients: CON. [PDF]
Aziz F, Parajuli S.
europepmc +1 more source
Immune Checkpoint Inhibitors and Cardiovascular Adverse Events
Abstract In the last years, we assisted to a tremendous increase in therapeutic options for the management of cancers, with immunotherapy at the forefront of this innovation. Immune checkpoint inhibitors (ICIs) have been developed to enhance the activity of the immune system against cancer cells (1) and the number of approvals for ICIs has rapidly ...
Maria Luisa De Perna+4 more
wiley +1 more source
The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates. [PDF]
Patrucco F+10 more
europepmc +1 more source
Evaluation of Clinical Parameters Associated with Response and Resistance to Cemiplimab in Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma: A Multi-Institutional Retrospective Cohort Study. [PDF]
Haigh JE+9 more
europepmc +1 more source
Abstract New Onset Refractory Status Epilepticus (NORSE) is a rare and severe condition characterized by refractory seizures in individuals without a prior history of epilepsy. This case report describes a 37‐year‐old woman diagnosed with anti‐glutamic acid decarboxylase 65 (anti‐GAD65) antibody‐positive encephalitis‐related NORSE.
Mingyu Li+9 more
wiley +1 more source
The effect of immunosuppression on outcomes in elderly patients with community-acquired pneumonia. [PDF]
Huang L+12 more
europepmc +1 more source
Inherited metabolic epilepsies–established diseases, new approaches
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley +1 more source
Is a Benign Disease Course Possible in Untreated AQP4-IgG NMOSD? [PDF]
Siriratnam P+5 more
europepmc +1 more source
Considering the rapid progression of cancer in most cases, any delay in evaluating therapy outcomes poses a significant threat to patients’ lives. Consequently, it is imperative to implement stratification and conduct timely evaluations of therapeutic effects either before or during the early stages of cancer treatment.
Qinrui Fu
wiley +1 more source